Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and
Frankfurt: “6BX”) (the “Company” or “Relevium”) is pleased to
announce it has entered into a Letter of Intent (“LOI”) with
H-Source Holdings, a leading secure and trusted Personal Protective
Equipment (“PPE”) platform, to partner in the development,
strategic sourcing and supply of global PPE requirements due to
COVID-19
BACKGROUNDOn March 2020, the
World Health Organization declared a global pandemic and as nations
around the world began to deal with the outbreak of COVID-19, the
market for PPE products and supplies saw a huge surge in demand
that created major gaps and inefficiencies in the supply chain.
As Relevium was introducing its first line of
defense Bioganix CleanCare, the entire market of PPE was faced with
major supply chain issues, lack of raw materials, non-compliant or
defective products and price gauging.
In May 2020 Relevium and H-Source begun
discussions about collaborating with the proprietary HS1 platform
to make accessible not only the CleanCare line of products but also
the core line of wellness products. HS1 is a fully secured and
auditable platform that connects buyers and suppliers in a secured,
compliant, and transparent manner. The platform is registered and
approved in over 35 States in the USA, as well as Canada, and
Europe, and partners with EY (formerly Ernst & Young) to
deploy the platform.
STRATEGIC PARTNERSHIPRelevium
and H-Source will be cooperating to list the Company’s needs and
offerings and recruiting its newly developed network of PPE vendors
and buyers onto the platform. Relevium’s new business, Bioganix
CleanCare is now poised to expand its current and rapidly growing
product offering through the H-Source platform thus globalizing the
current footprint of the Company.
Both companies have expressed their intention,
in the LOI, to exchange equity and share resources to solidify the
partnership.
John Kupice, CEO of H-Source stated, “We are
excited to partner with Aurelio and Relevium addiing Bioganix
and their other innovative products to the HS1 Global Virtual
Purchasing Organization Platform. Jointly we will service
current PPE needs as well as enable new efficient post COVID-19
supply chain processes and distribution models.”
Aurelio Useche, CEO of Relevium Technologies
stated: “We are extremely pleased to partner with John and his team
to develop and master the global supply chain of personal
protection products not only during this pandemic, but also to
service the New Economic standard of supplying services to
consumers. We look forward to a mutually rewarding and profitable
cooperation.”
About Relevium Technologies
Relevium is a publicly traded Company that
operates in the health and wellness industry, including legal
cannabis, with a primary focus on online distribution. The
principal business of the Company is the identification,
evaluation, acquisition and operation of brands and businesses in
the health and wellness markets and medical cannabis. The Company
pursues its business strategy through an acquisition and
partnership model in a holistic approach to encompass a wide range
of health and wellness consumer products. Relevium operates through
two wholly owned subsidiaries:
BGX E-Health LLC (BGX), based in Orlando,
Florida, markets dietary supplements, nutraceuticals, sports
nutrition, and cosmeceuticals primarily through its Bioganix® brand
portfolio in the US and Europe. Relevium’s premium brands are sold
at some of the world’s largest retailers including Walmart.com and
Amazon.com.
Biocannabix Health Corporation (BCX), based in
Montreal, Quebec, is a biopharma nutraceutical Company focused on
delivering pediatric endo-medicinal nutraceuticals for cannabinoid
therapy.
About H-Source Holdings Ltd.
H-Source Holdings Ltd. is a technology company operating within the
healthcare industry through its wholly owned subsidiaries,
H-Source, Inc. and H-Source Distribution, Inc. The Company has
developed a private, secure, and trusted transaction platform that
allows member medical facilities including hospitals and ASC's
(Ambulatory Surgery Centers) to buy, sell, track, and transfer
medical devices and supplies, pharmaceuticals, and capital
equipment with each other. Member medical facilities can
conduct secure transactions within their private groups or global
platform members. This marketplace network is specifically designed
to reduce health care costs and medical product waste, increase
cost recovery, and enable supply chain transformation and
efficiency.
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in policies
of the TSX Venture Exchange) accepts responsibility for the
adequacy or accuracy of this release.
Cautionary Note Regarding
Forward-Looking StatementsThis release includes certain
statements and information that may constitute forward-looking
information within the meaning of applicable Canadian and United
States securities laws. All statements in this news release, other
than statements of historical facts, including statements regarding
future estimates, plans, objectives, assumptions, or expectations
of future performance, are forward-looking statements and contain
forward-looking information. Generally, forward- looking statements
and information can be identified by the use of forward-looking
terminology such as "intends" or "anticipates", or variations of
such words and phrases or statements that certain actions, events
or results "may", "could", "should", or "would" occur.
Forward-looking statements are based on certain material
assumptions and analysis made by the Company and the opinions and
estimates of management as of the date of this press release. These
forward-looking statements are subject to known and unknown risks,
uncertainties and other factors that may cause the actual results,
level of activity, performance or achievements of the Company to be
materially different from those expressed or implied by such
forward-looking statements or forward-looking information.
Although management of the Company has attempted
to identify important factors that could cause actual results to
differ materially from those contained in forward-looking
statements or forward-looking information, there may be other
factors that cause results not to be as anticipated, estimated or
intended. There can be no assurance that such statements will prove
to be accurate, as actual results and future events could differ
materially from those anticipated in such statements. Accordingly,
readers should not place undue reliance on forward- looking
statements and forward-looking information. Readers are cautioned
that reliance on such information may not be appropriate for other
purposes. The Company does not undertake to update any
forward-looking statement, forward-looking information or financial
outlook that are incorporated by reference herein, except in
accordance with applicable securities laws. We seek to rely on the
applicable safe harbor.
On Behalf of the Board of Directors
RELEVIUM TECHNOLOGIES INC.
Aurelio UsechePresident and CEO
For more information about this press release:
Tel: +1.888.528.8687
RELEVIUM TECHNOLOGIES INCEmail:
investors@releviumcorp.comWebsite: www.releviumtechnologies.comLike
us on FacebookFollow us on TwitterFollow us on LinkedIn
Relevium Technologies (TSXV:RLV)
Historical Stock Chart
From Jun 2024 to Jul 2024
Relevium Technologies (TSXV:RLV)
Historical Stock Chart
From Jul 2023 to Jul 2024